FDA

FDA approves the use of Entresto

The U.S. Food and Drug Administration (FDA) already approved the use of the latest heart failure drug from Novartis. The drug, known as Entresto, was found to be potent in reducing death and hospitalizations related to cardiovascular diseases.

The Investigation into whether Johnson & Johnson Knew about their Harmful Uterine Device

Johnson & Johns is under investigation by the FBI for possible prior knowledge about dangers linked to one of their medical devices, the laparoscopic power morcellator, which is supposed to provide a minimally invasive alternative to hysterectomies and removal of fibroid tumors, but in reality, may have been spreading dangerous forms of cancers among its patients.

Pfizer Announces IBRANCE Clinical Trials Ended Early In Light of Promising News

In light of promising results conducted by an independent data monitoring committee, Pfizer’s newest treatment IBRANCE (Palbociclib) ended clinical trials early this week as phase 3 of the trials ended demonstrating improvement in progression-free survival in women who had undergone treatment for metastatic breast cancer.

FDA Issues Warning for the Quit-Smoking Drug Chantix

Chantix has helped many people quit smoking in the years since its release. However, on Monday the U.S. Food and Drug Administration issued a warning about the quit-smoking drug made by Pfizer Inc. According to the FDA, the drug has been associated with seizures and that some patients who drink while taking the drug may become aggressive or even black out.

Novartis Seeking Approval for Medication to Treat 'Smoker's Cough'

Novartis AG, a Swiss drug maker, is seeking U.S. regulatory approval for two new drugs designed to treat chronic obstructive pulmonary disease (COPD), otherwise known as "smoker's cough". Approval of the drugs could generate an additional $1.4 billion for the company, while helping chronic smokers breathe a little clearer in the process.

Drug Approvals Reached New High in 2014: What's Next?

Approvals for medicine in the United States have reached their highest levels in eighteen years, and recommendations for new drugs in Europe also came at a rapid rate, driven by expensive new treatments for cancer and other rare and serious diseases. After enduring wave after wave of patent losses on some of their larger, more popular drugs, pharmaceutical firms are beginning to recover by bringing new medicines to the market, while also improving their productivity.

FDA Approves a Fast-Acting Ebola Test

The fight to stop Ebola continues to rage on across the world as researchers continue to find new ways to both detect and treat the deadly virus. The U.S. Food and Drug Administration (FDA) has just approved a new test to detect the virus in patients believed to be suffering from the virus.

Caramel Apples May Not Be So Sweet—Listeria Outbreak Across US

This holiday season you may want to steer clear of the sweets—or at least caramel apples. Though the caramel sweets are often an Autumn/Winter treat, health officials with the US Centers of Disease Control and Prevention (CDC) are saying that they may be the link between a multi-state Listeria outbreak that has to date led to more than four deaths, and dozens of hospitalizations. Reporting this morning, Dec. 19, on the condition of the outbreak, the CDC says that at least 28 individuals spanning the states of Arizona, Texas and Minnesota have been infected and are facing the life-threatening illness.
1 2 3 4 5 6 7 8
Most Popular

Recommended Stories

Real Time Analytics